We developed a PD-L1 staining protocol for tumor cells enriched by the Parsortix system by spiking PD-L1+ H1975 vs. PD-L1− MCF7 cells in whole blood obtained from healthy donors. The gene discussed is CD274; the disease is neoplasm.